NCT06173362 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06173362
Title	Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer
Recruitment	Recruiting
Gender	male
Phase	Phase II
Variant Requirements	No
Sponsors	Mamta Parikh
Indications	prostate adenocarcinoma
Therapies	Darolutamide Abiraterone + Prednisone
Age Groups:	adult \| senior
Covered Countries	USA

Filter rows:

Showing 1 to 1 of 1 entries

Facility	Status	City	State	Zip	Country	Details
University of California Davis Comprehensive Cancer Center	RECRUITING	Sacramento	California	95817	United States	Details

Showing 1 to 1 of 1 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06173362Clinical Trial Detail